000 01735 a2200457 4500
005 20250515234042.0
264 0 _c20101028
008 201010s 0 0 eng d
022 _a1932-6203
024 7 _a10.1371/journal.pone.0011858
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZietsch, Jan
245 0 0 _aThe 4q12 amplicon in malignant peripheral nerve sheath tumors: consequences on gene expression and implications for sunitinib treatment.
_h[electronic resource]
260 _bPloS one
_cJul 2010
300 _ae11858 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aApoptosis
650 0 4 _aBlotting, Western
650 0 4 _aCell Line, Tumor
650 0 4 _aHumans
650 0 4 _aImmunohistochemistry
650 0 4 _aIn Vitro Techniques
650 0 4 _aIndoles
_xtherapeutic use
650 0 4 _aNerve Sheath Neoplasms
_xdrug therapy
650 0 4 _aProto-Oncogene Proteins c-kit
_xgenetics
650 0 4 _aPyrroles
_xtherapeutic use
650 0 4 _aReceptor, Platelet-Derived Growth Factor alpha
_xgenetics
650 0 4 _aReverse Transcriptase Polymerase Chain Reaction
650 0 4 _aSignal Transduction
_xdrug effects
650 0 4 _aSunitinib
650 0 4 _aVascular Endothelial Growth Factor A
_xgenetics
650 0 4 _aVascular Endothelial Growth Factor Receptor-2
_xgenetics
700 1 _aZiegenhagen, Nicolas
700 1 _aHeppner, Frank L
700 1 _aReuss, David
700 1 _avon Deimling, Andreas
700 1 _aHoltkamp, Nikola
773 0 _tPloS one
_gvol. 5
_gno. 7
_gp. e11858
856 4 0 _uhttps://doi.org/10.1371/journal.pone.0011858
_zAvailable from publisher's website
999 _c20025248
_d20025248